PubRank

C Fonatsch

Author PubWeight™ 123.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci U S A 1991 3.27
2 Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 1991 2.33
3 Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group. Blood 1999 1.56
4 Characteristics of Hodgkin's disease-derived cell lines. Cancer Treat Rep 1982 1.51
5 Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group. Leukemia 2000 1.51
6 Hodgkin's disease: establishment and characterization of four in vitro cell lies. J Cancer Res Clin Oncol 1981 1.50
7 Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q. Leukemia 2010 1.48
8 A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis. Ann Hematol 2002 1.44
9 Correlation of chromosomal aberrations in a myeloma cell line with tumorigenicity in nude mice. Blut 1981 1.40
10 Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS). Leukemia 2005 1.38
11 The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen. Eur J Immunol 1994 1.32
12 Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 1996 1.26
13 Management of acute myeloid leukemia in elderly patients. J Clin Oncol 1999 1.25
14 High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia 2005 1.24
15 Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients. Br J Haematol 2001 1.21
16 Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells. Blood 1996 1.20
17 Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients. Leukemia 2000 1.18
18 Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption. Hum Mutat 2007 1.17
19 Two neoplastic cell lines with unique features derived from Hodgkin's disease. Int J Cancer 1980 1.14
20 Molecular characteristics of HGF-SF and its role in cell motility and invasion. EXS 1993 1.10
21 High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia. Leukemia 2004 1.09
22 MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis. Blood 1998 1.08
23 Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89. Blood 1998 1.08
24 Preferential maternal derivation in inv dup(15): analysis of eight new cases. Hum Genet 1981 1.08
25 Incidence and implication of additional chromosome aberrations in acute promyelocytic leukaemia with translocation t(15;17)(q22;q21): a report on 50 patients. Br J Haematol 1996 1.07
26 Partial trisomy 1q due to tandem duplication. Clin Genet 1979 1.05
27 A simple method to demonstrate the fragile X chromosome in fibroblasts. Hum Genet 1981 1.03
28 The human vigilin gene: identification, chromosomal localization and expression pattern. Hum Genet 1994 1.02
29 Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse. Leukemia 2004 1.02
30 Balanced reciprocal whole-arm translocation t(1;19) in three generations. Hum Genet 1978 1.01
31 Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor. Leukemia 1996 1.00
32 dic(9;20): a new recurrent chromosome abnormality in adult acute lymphoblastic leukemia. Genes Chromosomes Cancer 1995 1.00
33 Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations. Blood 1995 0.99
34 Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes. Ann Oncol 2008 0.98
35 Illegitimate splicing of the NF1 gene in healthy individuals mimics mutation-induced splicing alterations in NF1 patients. Hum Genet 2000 0.98
36 Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes. Leuk Res 2001 0.97
37 Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors. Bone Marrow Transplant 1998 0.97
38 Phenotypic and genotypic analysis of Hodgkin's disease derived cell lines: histopathological and clinical implications. Cancer Surv 1985 0.97
39 The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase. Br J Haematol 2001 0.95
40 Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma. Lab Invest 1996 0.94
41 Phenotype versus immunoglobulin and T-cell receptor genotype of Hodgkin-derived cell lines: activation of immature lymphoid cells in Hodgkin's disease. Int J Cancer 1987 0.93
42 Replication pattern in XXY cells with fra(X). Hum Genet 1982 0.92
43 Persistent Epstein-Barr virus infection associated with monosomy 7 or chromosome 3 abnormality in childhood myeloproliferative disorders. Br J Haematol 1985 0.92
44 The abnormal eosinophils are part of the leukemic cell population in acute myelomonocytic leukemia with abnormal eosinophils (AML M4Eo) and carry the pericentric inversion 16: a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization. Blood 1996 0.91
45 The fusion of TEL and ABL in human acute lymphoblastic leukaemia is a rare event. Br J Haematol 1995 0.90
46 The translocation (6;9) (p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features. Blood 1992 0.90
47 Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS). Leukemia 1999 0.90
48 Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance. Leuk Lymphoma 1999 0.90
49 Regional mapping of the gene for autosomal dominant spinocerebellar ataxia (SCA1) by localizing the closely linked D6S89 locus to 6p24.2----p23.05. Cytogenet Cell Genet 1992 0.89
50 Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system. Cancer Res 1994 0.89
51 Monosomal karyotype in MDS: explaining the poor prognosis? Leukemia 2013 0.89
52 Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome. Genes Chromosomes Cancer 2000 0.88
53 Correlation of cytogenetic, molecular cytogenetic, and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12. Br J Haematol 1998 0.88
54 Gene expression signature of chronic lymphocytic leukaemia with Trisomy 12. Eur J Clin Invest 2009 0.88
55 Massive disseminated intravascular coagulation and hyperfibrinolysis in alveolar rhabdomyosarcoma: case report and review of the literature. Ann Hematol 1999 0.87
56 The cell of origin in Hodgkin's disease. Semin Oncol 1990 0.87
57 Transcription factor GATA-2 gene is located near 3q21 breakpoints in myeloid leukemia. Biochem Biophys Res Commun 2000 0.87
58 Assignment of the TCP1 locus to the long arm of human chromosome 6 by in situ hybridization. Cytogenet Cell Genet 1987 0.86
59 De novo AML with dysplastic hematopoiesis: cytogenetic and prognostic significance. Leukemia 1996 0.86
60 A possible correlation between the degree of karyotype aberrations and the rate of sister chromatid exchanges in lymphoma lines. Int J Cancer 1980 0.86
61 De novo (11;13) translocation. Humangenetik 1975 0.86
62 Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia. Br J Haematol 1996 0.86
63 Establishment of a malignant, Epstein-Barr-virus (EBV)-negative cell-line from the pleura effusion of a patient with Hodgkin's disease. Blut 1979 0.85
64 Alveolar rhabdomyosarcoma in a 68-year-old patient identified by cytogenetic analysis of bone marrow. Cancer Genet Cytogenet 1998 0.85
65 Prospective BCR-ABL analysis by polymerase chain reaction (RT-PCR) in adult acute B-lineage lymphoblastic leukemia: reliability of RT-nested-PCR and comparison to cytogenetic data. Leukemia 2001 0.85
66 Growth of Hodgkin cell lines in severely combined immunodeficient mice. Int J Cancer 1992 0.85
67 The Met/hepatocyte growth factor receptor (HGFR) gene is overexpressed in some cases of human leukemia and lymphoma. Leuk Res 1994 0.84
68 Cell lines of human germinal cancer. Int J Androl 1987 0.84
69 Preliminary report: growth of Hodgkin's lymphoma derived cells in immune compromised mice. Ann Oncol 1992 0.84
70 Acute myeloid leukemia with translocation (8;21). Cytomorphology, dysplasia and prognostic factors in 41 cases. AML Cooperative Group and ECOG. Leuk Lymphoma 1996 0.84
71 Regional sublocalization of the human CD69 gene to chromosome bands 12p12.3-p13.2, the predicted region of the human natural killer cell gene complex. Eur J Immunol 1993 0.84
72 Intracranial heterotransplantation of human hematopoietic cells in nude mice. Int J Cancer 1979 0.83
73 Drug resistance factors in acute myeloid leukemia: a comparative analysis. Leukemia 2000 0.83
74 High rate of chromosome abnormalities detected by fluorescence in situ hybridization using BCR and ABL probes in adult acute lymphoblastic leukemia. Leukemia 1998 0.83
75 The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. German AML Cooperative Study Group. Br J Haematol 1997 0.83
76 Cytogenetic findings in 179 patients with myelodysplastic syndromes. Ann Hematol 1995 0.83
77 Myeloid- and lymphoid-specific breakpoint cluster regions in chromosome band 13q14 in acute leukemia. Genes Chromosomes Cancer 1999 0.82
78 Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia. Ann Hematol 1999 0.82
79 Establishment and characterization of a seminoma cell-line (S2). Investig Urol (Berl) 1994 0.82
80 Recombinant human interferon (IFN) alpha-2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti-interferon antibodies. Br J Haematol 1989 0.82
81 Pre-pre-B acute lymphoblastic leukemia: high frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remission. Blood 1994 0.82
82 High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia. A single center study. Am J Clin Pathol 2000 0.82
83 Partial trisomy 4q and partial monosomy 18q as a consequence of a paternal balanced translocation t(4qminus; 18qplus). Humangenetik 1974 0.82
84 Comparative expression analysis of the antagonistic transcription factors EVI1 and MDS1-EVI1 in murine tissues and during in vitro hematopoietic differentiation. Biochem Biophys Res Commun 1998 0.82
85 Cytogenetic investigations in Hodgkin's disease: I. Involvement of specific chromosomes in marker formation. Cancer Genet Cytogenet 1986 0.82
86 Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR. Leukemia 1999 0.81
87 Heterochromatin and nucleolus organizer regions in cells of patients with malignant and premalignant lymphatic diseases. Hum Genet 1984 0.81
88 Twenty-three cases of acute lymphoblastic leukemia with translocation t(4;11)(q21;q23): the implication of additional chromosomal aberrations. Ann Hematol 1995 0.81
89 Characterization, mapping and partial cDNA sequence of the 57-kD intracellular Ki-1 antigen. Exp Clin Immunogenet 1997 0.80
90 Hodgkin's lymphoma-derived tissue serially transplanted into severe combined immunodeficient mice. Blood 1993 0.80
91 T-cell acute childhood lymphoblastic leukemia with chromosome 14 q 11 anomaly: a morphologic, immunologic, and cytogenetic analysis of 10 patients. Blut 1988 0.80
92 Three different premature stop codons lead to skipping of exon 7 in neurofibromatosis type I patients. Hum Mutat 2000 0.80
93 Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories. Ann Oncol 2010 0.80
94 Somatic mosaicism of a greater than 1.7-Mb deletion of genomic DNA involving the entire NF1 gene as verified by FISH: further evidence for a contiguous gene syndrome in 17q11.2. Am J Med Genet 1999 0.79
95 Childhood T-cell non-Hodgkin's lymphoma, colorectal carcinoma and brain tumor in association with café-au-lait spots caused by a novel homozygous PMS2 mutation. Leukemia 2007 0.79
96 Disseminated growth of Hodgkin's-derived cell lines L540 and L540cy in immune-deficient SCID mice. Ann Oncol 1994 0.79
97 Long-term cultivation of plasma cell leukemia cells and autologous lymphoblasts (LCL) in vitro: a comparative study. Blut 1978 0.79
98 Sequential gene expression profiling during treatment for identification of predictive markers and novel therapeutic targets in chronic lymphocytic leukemia. Leukemia 2010 0.79
99 Hodgkin's disease cell lines: characteristics and biological activities. Haematol Blood Transfus 1983 0.79
100 Hodgkin's cell lines: characteristics and possible pathogenetic implications. Hematol Oncol 1984 0.79
101 Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells. Am J Hematol 1999 0.79
102 Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems. Ann Hematol 2001 0.78
103 Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSF. Leukemia 2001 0.78
104 The cell of origin in Hodgkin's disease: conclusions from in vivo and in vitro studies. Int Rev Exp Pathol 1985 0.78
105 Mapping of leukaemia-associated breakpoints in chromosome band 3q21 using a newly established PAC contig. Br J Haematol 2000 0.78
106 Localization of the undulin gene (UND) to human chromosome band 8q23. Cytogenet Cell Genet 1995 0.78
107 Monosomy 7 provides a proliferative advantage for leukemic cells under incubation with GM-CSF in vitro. Blut 1990 0.78
108 Extramedullary T cell lymphoblastic transformation of chronic myeloid leukaemia successfully treated with matched unrelated donor bone marrow transplantation. Bone Marrow Transplant 2000 0.77
109 Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromes. J Cancer Res Clin Oncol 1999 0.77
110 Prognosis of patients with a second relapse of acute myeloid leukemia. Leukemia 2000 0.77
111 Translocation (14; 18) and (8; 22) in three patients with acute leukemia/lymphoma following centrocytic/centroblastic non-Hodgkin's lymphoma. Ann Hematol 1991 0.77
112 17p anomalies in lymphoid malignancies: diagnostic and prognostic implications. Leuk Lymphoma 1995 0.77
113 Mutational analysis of the tumor suppressor Smad2 in acute lymphoid and myeloid leukemia. Leukemia 1998 0.77
114 Monosomy 6 in a human lymphoma line induced by selection with a monoclonal antibody. Immunobiology 1985 0.77
115 Refinement of HLA gene mapping with induced B-cell line mutants. Immunogenetics 1985 0.77
116 Partial trisomy 13 plus partial trisomy 4q due to unusual segregation of translocation chromosomes. Clin Genet 1979 0.77
117 Morphological and cytochemical findings in 150 cases of T-lineage acute lymphoblastic leukaemia in adults. German Multicentre ALL Study Group (GMALL). Br J Haematol 1997 0.77
118 Translocation (6;9)(p23;q34) in smoldering leukemia and acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1987 0.77
119 Sister chromatid exchange in cell lines from malignant lymphomas (lymphoma lines). Hum Genet 1979 0.77
120 Familial cryptic translocation with del 4q34-->qter and dup 12pter-->p13 in sibs with tracheal stenosis: clinical, classical and molecular cytogenetic studies and CGH analyses from archival placental tissues evidencing tertiary trisomy 4 in one abortion specimen. Am J Med Genet 2000 0.77
121 New chromosome polymorphism: inv(16)(p11q12 or 13). Cytogenet Cell Genet 1977 0.77
122 Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. The AML Cooperative Group. Ann Hematol 1993 0.76
123 Interphase fluorescence in situ hybridization assay for the detection of 3q21 rearrangements in myeloid malignancies. Genes Chromosomes Cancer 2001 0.76
124 Subgroup specific therapy effects in AML: AMLCG data. Ann Hematol 2004 0.76
125 G-CSF in the long-term treatment of cyclic neutropenia and chronic idiopathic neutropenia in adult patients. Int J Hematol 1995 0.76
126 Polymerase chain reaction analysis of BCR-ABL sequences in adult Philadelphia chromosome-negative acute lymphoblastic leukemia patients. Leukemia 1992 0.76
127 Establishment and characterization of a novel CD34-positive human myeloid leukemia cell line: MHH225 growing in serum-free culture. Ann Hematol 1995 0.76
128 [Comparison of flow cytometric, static cytometry and tumor cytogenetic investigation results human renal cell carcinomas]. Verh Dtsch Ges Pathol 1990 0.76
129 Activation of a novel gene in 3q21 and identification of intergenic fusion transcripts with ecotropic viral insertion site I in leukemia. Cancer Res 1997 0.76
130 Cytogenetic risk groups in acute myeloblastic leukaemia differ greatly in their semi-solid colony growth. Br J Haematol 2001 0.76
131 Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYH11 RT-PCR: implications for a monitoring schedule and for treatment decisions. Leuk Lymphoma 2001 0.75
132 Loss of heterozygosity in the Hodgkin-Reed Sternberg cell line L1236. Br J Cancer 2001 0.75
133 Secondary lymphoblastic leukemia following treatment of a malignant germ cell tumour. Ann Oncol 1992 0.75
134 Abnormalities of the short arm of chromosome 9. A nonrandom secondary aberration in Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL) Cancer Genet Cytogenet 1991 0.75
135 A case of atypical myelodysplastic syndrome with micromegakaryocytes, normal platelet count, and t(3;12)(q21;p13) with inv(3)(q21q26). Genes Chromosomes Cancer 1997 0.75
136 Masked inv(3)(q21q26) in a patient with minimally differentiated acute myeloid leukemia. Haematologica 2001 0.75
137 Amplification of the AML1(CBFA2) gene on ring chromosomes in a patient with acute myeloid leukemia and a constitutional ring chromosome 21. Cancer Genet Cytogenet 2001 0.75
138 Effect of nitrofurantoin on meiosis of the male mouse. Hum Genet 1977 0.75
139 [Morphology and growth characteristics of human renal cell carcinoma in correlation to cytogenetic data]. Verh Dtsch Ges Pathol 1989 0.75
140 H-Y antigen in male patients with X polysomies. Hum Genet 1982 0.75
141 Translocation of c-abl oncogene and PDGFB (c-sis) gene in a case of CML with 46,XY, t(22;22). Blut 1989 0.75
142 Variant intra philadelphia translocation with rearrangement of BCR-ABL and ABL-BCR within the same chromosome in a patient with cALL. Cancer Genet Cytogenet 2000 0.75
143 Chromosomal abnormalities in adult acute lymphoblastic leukemia: results of the German ALL/AUL Study Group. Recent Results Cancer Res 1993 0.75
144 [Cytogenetic of malignant lymphomas]. Dtsch Med Wochenschr 1982 0.75
145 Fluorescence in situ hybridization characterization of the chromosomal breakpoints in a case with ins(17;3)(q11.2;q21q26.3) and acute monocytic leukemia. Cancer Genet Cytogenet 1998 0.75
146 Non-lymphocytic leukaemia following chemotherapy of a germ cell tumour. Br J Urol 1997 0.75
147 [Therapy of chronic myeloid leukemia with interferon-alpha. A decade of experiences]. Med Klin (Munich) 1996 0.75
148 Reciprocal translocation (3;5)(q26;q22) and possible BCHE gene involvement in an unusual myelogenous disorder with both myeloproliferative and dysplastic features. Cancer Genet Cytogenet 2000 0.75
149 Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversioin inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26). Ann Hematol 2000 0.75
150 Biology of Hodgkin cell lines. Recent Results Cancer Res 1989 0.75
151 [Cytogenetics of juvenile tumors]. Dtsch Med Wochenschr 1985 0.75
152 Karyotype and in vitro-response to GM-CSF. Analysis of bone marrow cultures in leukemia, myelodysplasia and aplastic anemia. Blut 1990 0.75
153 Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood and adult de novo AML. Leuk Lymphoma 1995 0.75
154 Chromosome analyses in man in the course of chemoprophylaxis against tuberculosis and of antituberculosis chemotherapy with isoniazid. Hum Genet 1978 0.75
155 Translocation t(1;22) mimicking t(1;19) in a child with acute lymphoblastic leukemia as revealed by chromosome painting. Leukemia 1993 0.75
156 Frequency of sister chromatid exchanges in a balanced reciprocal whole-arm translocation. Hum Genet 1979 0.75
157 Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia. Leukemia 2004 0.75
158 CD34 expression in de novo acute myeloid leukaemia. Br J Haematol 1993 0.75
159 Analysis of bcr rearrangements in primary (essential) thrombocythaemia. Leuk Res 1990 0.75
160 Translocation t(8;22) in peripheral lymphocytes and established lymphoid cell lines from a patient with Hodgkin's disease followed by acute lymphatic leukemia. Int J Cancer 1982 0.75
161 Hodgkin's disease: the remaining challenge. Prog Med Virol 1984 0.75
162 [The therapy of acute myeloid leukemia in patients of advanced age]. Dtsch Med Wochenschr 1999 0.75
163 [Clinical research at the European LeukemiaNet]. Dtsch Med Wochenschr 2006 0.75
164 Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants. Leukemia 2001 0.75
165 Refined chromosomal localization of the human thrombopoietin gene to 3q27-q28 and exclusion as the responsible gene for thrombocytosis in patients with rearrangements of 3q21 and 3q26. Leukemia 1996 0.75
166 Chromosomal aberrations during interferon therapy for chronic myelogenous leukemia. N Engl J Med 1991 0.75
167 Recent efforts to establish an in vivo model as a new experimental tool in the study of Hodgkin's disease. Eur J Cancer 1992 0.75
168 A new translocation--t(13;21)(q14;q22.1 or 21.2)--in acute myelogenous leukemia. Cancer Genet Cytogenet 1986 0.75
169 Sister chromatid exchange in lymphoma line and lymphoblastoid cell lines before and after heterotransplantation into nude mice. Int J Cancer 1981 0.75
170 Characterization of rearranged Y chromosomes in human testicular tumor cell lines. Cancer Genet Cytogenet 1989 0.75
171 [Fragile X chromosome and X-linked mental retardation (author's transl)]. Wien Klin Wochenschr 1982 0.75
172 Cytogenetic markers in hematoproliferative disorders. Blut 1985 0.75
173 Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia. Ann Hematol 2000 0.75
174 [Primary (essential) thrombocythemia. Clinical findings, course and therapy in 26 patients]. Med Klin (Munich) 1987 0.75
175 T-cell receptor gamma/delta expressing acute leukemia emerging from sideroblastic anemia: morphological, immunological, and cytogenetic features. Leuk Res 1992 0.75
176 Karyotype instability in myelodysplastic syndromes--a specific step in pathogenesis preceding clonal chromosome anomalies. Leuk Lymphoma 1992 0.75
177 Rearrangements of immunoglobulin- and BCR-genes in chronic myeloid leukemia. In Vivo 1991 0.75
178 [Properties of Hodgkin cell lines. Possible significance for pathophysiology and clinical medicine]. Dtsch Med Wochenschr 1983 0.75
179 Cytogenetic peculiarities in chronic myelogenous leukemia. Cancer Genet Cytogenet 1990 0.75
180 Lymphoproliferation and heterotransplantation in nude mice: tumor cells in Hodgkin's disease. Haematol Blood Transfus 1981 0.75
181 Frequency of fragile X chromosomes, fra(X), in lymphocytes in relation to blood storage time and culture techniques. Hum Genet 1983 0.75
182 A technique for simultaneous demonstration of G bands and sister chromatoid exchanges. Cytogenet Cell Genet 1979 0.75